documents: FDA-2021-D-0691-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-D-0691-0001 FDA FDA-2021-D-0691 Pharmacokinetic-Based Criteria for Supporting Alternative Dosing Regimens of Programmed Cell Death Receptor-1 or Programmed Cell DeathLigand 1 Blocking Antibodies for Treatment of Patients With Cancer; Draft Guidance for Industry; Availability Notice Notice of Availability 2021-08-26T04:00:00Z 2021 8 2021-08-26T04:00:00Z 2021-10-26T03:59:59Z 2021-10-26T01:00:33Z 2021-18317 0 0 0900006484ca8bc7

Links from other tables